Aug. 14 at 4:02 PM
$TNFA @ @DougieFreshPicks How does
$TNFA isomyosamine COMPAIR ✅️ TNF-alpha inhibitors of
$ABT's Blocker has 🎯 "Black Box Warning" =Dangers of serious complications.🎯
$ABT $41 Billion revenue ✅️ ✨ ✨READ issues Below of
$AMGN &
$ABT✨ ✨
Adalimumab (Humira) & isomyosamine (MYMD-1) both 🎯 target TNF-alpha (TNF-α), a Key inflammatory Ctokine, but there are some CRITICAL distinctions between them:🎯
✅️
$ABT's (Humira)generally effective, ✨✨ DD evidence indicates adalimumab may BROADLY affect the total immune system ✨ ✨ potentially lead to several serious side effects. ✅️ Isomyosamine has been ✨ ✨ shown be able to achieve TNF-α inhibition without suppressing the Beneficial functions of TNF-α involved as First responder to normal infections. ✨ ✨
Blood-brain barrier penetration = Important🎯 🎯
Adalimumab ✅️
$ABT's &
$AMGN's Enbrel does Not easily cross the blood-brain barrier if at all on low safer doses. = IMPORTANT ✅️
Isomyosamine
$TNFA's has✨ ✨ demonstrated the ability to cross the blood-brain barrier, expanding key therapeutic applications to Brain-Related Disorders✨ ✨ where inflammation plays a big role. 🎯🎯
In print side effects of Adalimumab:
✅️ ✅️
$ABT's =✨"Black Box Warnings" Danger ✅️ ✅️ for the🎯 risk of several Serious Infections and organ damage.= in print in Research 🎯
TIA for Key excepts few paraphrased for clarity from long scientific dissertation for knowledgeable DD members.
🎯 Falling wedge chart price pattern is a bullish pattern characterized by converging trendlines, indicating a likely reversal up. Slowing of downward momentum with likely positive shift in market sentiment finally from price Breakout above wedge. 🎯
